title: Vaginal Cerclage: Preoperative, Intraoperative, and Postoperative Management.
abstract: The role of the cerclage procedure has expanded from its initial application as treatment or prevention of cervical insufficiency to prevention of recurrent spontaneous preterm birth. Although recent prospective studies have clarified the indications for cerclage, additional prospective studies are needed to help define optimal perioperative management. Herein, we review the current data to provide the clinician with the most evidence-based approach to managing patients who require cerclage.
authors.affiliation: Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, University of Alabama at Birmingham, Birmingham, Alabama.
authors.forename: S Lindsay
authors.initials: SL
authors.lastname: Wood
authors.forename: John
authors.initials: J
authors.lastname: Owen
mesh_terms: D000077713:17 alpha-Hydroxyprogesterone Caproate; D000649:Amniocentesis; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000891:Anti-Infective Agents, Local / Q000627:therapeutic use; D023802:Cerclage, Cervical / Q000379:methods; D054791:Cervical Length Measurement; D020878:Device Removal; D037001:Directive Counseling; D005260:Female; D005322:Premature Rupture of Fetal Membranes / Q000601:surgery; D006801:Humans; D006908:Hydroxyprogesterones / Q000627:therapeutic use; D019990:Perioperative Care / Q000379:methods*; D010808:Physical Examination; D011247:Pregnancy; D047928:Premature Birth / Q000209:etiology / Q000517:prevention & control*; D011391:Prolapse; D055502:Secondary Prevention; D013536:Suture Techniques; D013537:Sutures; D002581:Uterine Cervical Incompetence / Q000175:diagnosis*
chemical_list: D000900:Anti-Bacterial Agents; D000891:Anti-Infective Agents, Local; D006908:Hydroxyprogesterones; D000077713:17 alpha-Hydroxyprogesterone Caproate